Profiling iron-regulated metabolic reprogramming for nucleotide biosynthesis in colon tumors
分析结肠肿瘤中核苷酸生物合成的铁调节代谢重编程
基本信息
- 批准号:10202652
- 负责人:
- 金额:$ 26.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAnimal ModelAspartateAutomobile DrivingBiologyCancer EtiologyCancer ModelCarbamyl PhosphateCell ProliferationCell SurvivalCellsCessation of lifeClinicColonColonic NeoplasmsColorectal CancerConsumptionDNA Polymerase IIIDNA biosynthesisDNA-Directed DNA PolymeraseDataDeferoxamineDevelopmentDietDihydroorotaseEnzymesExhibitsFutureGeneticGlucoseGlutamineGlycolysisGoalsGrowthHumanHypoxiaIncidenceIronIron ChelationKnock-outKnowledgeLigaseLinkMCC geneMacronutrients NutritionMalignant NeoplasmsMeasuresMediatingMedicineMetabolicMetabolismMetalsMethodsMolecularMusNew MexicoNormal CellNucleotide BiosynthesisNucleotidesPDH kinasePathway interactionsPatientsPentosephosphate PathwayPharmacologyPolymerasePyrimidineRepressionRoleSLC2A1 geneSignal TransductionTP53 geneTestingTherapeuticTissuesTumor-DerivedUniversitiesUridine KinaseWorkbasecBioPortalcancer cellcancer genomicscancer riskcell growthcolon cancer patientscolon carcinogenesiscolon tumorigenesiscolorectal cancer progressionepidemiology studyglucose metabolismimprovedinhibitor/antagonistiron supplementmetabolomicsneoplastic cellnovel therapeutic interventionnovel therapeuticsnucleotide metabolismstable isotopetranscarbamylasetumortumor growth
项目摘要
Colorectal cancer (CRC) is the third leading cause of cancer-related death in US. Understanding the
mechanisms of CRC development is essential to improve treatment. Increased tissue iron in both mice and
humans is associated with increased colon tumorigenesis. However, the precise mechanisms for how iron
contributes to colon carcinogenesis are still unclear. The metabolic differences between normal and cancer
cells are being interrogated to uncover potential new therapeutic approaches. Many tumor cells exhibit
increased glucose consumption, glutamine metabolism and nucleotide synthesis. This proposal will test the
central hypothesis that iron-driven cellular metabolic reprograming promotes DNA synthesis and colon
tumorigenesis. This hypothesis is based on: 1) iron supplement increases, whereas chelation of iron by
deferoxamine (DFO) inhibits the growth and cell proliferation of patient-derived CRC colonoids; 2) treating mice
with high-iron diet increases, while low-iron diet decreases colon tumor multiplicity, incidence and progression;
3) metabolomics analysis reveals that excess iron impacts glucose-stimulated nucleotide synthesis by
promoting hypoxia-independent “Warburg-like effect” and fueling pentose phosphate pathway in colonoids; 4)
iron restriction by DFO leads to glutamine accumulation and reduction of metabolites in nucleotide biosynthesis
pathways in colonoids. Based on these observations, the proposal will test the following three Specific Aims: 1)
Define the mechanism by which excess iron affects glucose-stimulated DNA biosynthesis in CRC; 2) Study the
impact of iron restriction on glutamine-dependent nucleotide synthesis in CRC; 3) Characterize the role of a
DNA polymerase in iron-regulated nucleotide metabolism and CRC. We will utilize highly clinic-relevant CRC
patient-derived colonoid culture, metabolomics analysis, and various animal models. Accomplishing the above
Aims will provide precise molecular mechanisms for how tumor cells are adapted to iron signal to synthesize
nucleotides for facilitating tumor proliferation. These studies will fill our knowledge gap of how iron regulates
CRC growth and progression.
结直肠癌(CRC)是美国与癌症相关死亡的欺骗原因
CRC发育的机制对于提高了小鼠的组织至关重要。
人类与结肠肿瘤的增加有关。
造成结肠癌的作用仍不清楚。
细胞正在审问以发现潜在的新治疗方法。
增加葡萄糖消耗,谷氨酰胺代谢和核苷酸合成。
铁驱动的细胞代谢重编程促进了DNA合成和结肠的中心假设
肿瘤发生。该假设基于:1)铁的增加
脱氧胺(DFO)抑制了治疗小鼠的患者CRC结构化的生长和细胞增殖
随着高铁饮食的增加,低铁饮食将结肠肿瘤的多重性,发病率和进度降低;
3)代谢组学分析启示过多铁会影响葡萄糖刺激的核苷酸合成
促进缺氧 - 类似于沃尔伯格的效应,并在菌群中加油。
DFO限制铁导致谷氨酰胺的积累和核苷酸生物合成中代谢产物的减少
Coloronoid中的途径。
定义过量铁影响CRC中葡萄糖诱导的DNA生物合成的机制;
铁限制对CRC中谷氨酸依赖性核苷酸合成的影响;
铁制的核苷酸代谢和CRC中的DNA聚合酶。
患者衍生的结肠培养,代谢组学分析和各种动物模型
目的将使肿瘤细胞如何适应铁信号的分子机制来合成
核苷酸促进肿瘤增殖。
CRC的增长和进步。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xiang Xue其他文献
Xiang Xue的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xiang Xue', 18)}}的其他基金
Profiling iron-regulated metabolic reprogramming for nucleotide biosynthesis in colon tumors
分析结肠肿瘤中核苷酸生物合成的铁调节代谢重编程
- 批准号:
10408034 - 财政年份:2020
- 资助金额:
$ 26.37万 - 项目类别:
Profiling iron-regulated metabolic reprogramming for nucleotide biosynthesis in colon tumors
分析结肠肿瘤中核苷酸生物合成的铁调节代谢重编程
- 批准号:
10629363 - 财政年份:2020
- 资助金额:
$ 26.37万 - 项目类别:
Targeting Mitochondrial Iron Metabolism in Inflammatory Bowel Disease
靶向炎症性肠病的线粒体铁代谢
- 批准号:
9757782 - 财政年份:2017
- 资助金额:
$ 26.37万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
利用肝癌动物模型开展化学可控的在体基因编辑体系的研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Aspartate beta-hydroxylase and DNA damage in chronic liver diseases
慢性肝病中的天冬氨酸 β-羟化酶和 DNA 损伤
- 批准号:
10667881 - 财政年份:2023
- 资助金额:
$ 26.37万 - 项目类别:
Mechanisms of NMDAR contribution to traumatic injury in retinal ganglion cells
NMDAR对视网膜神经节细胞创伤性损伤的作用机制
- 批准号:
10570666 - 财政年份:2023
- 资助金额:
$ 26.37万 - 项目类别:
Rusalatide Acetate (TP508) Mitigation Effect on Radiation Induced Keratopathy
醋酸鲁沙来肽 (TP508) 对放射诱发的角膜病变的缓解作用
- 批准号:
10605739 - 财政年份:2023
- 资助金额:
$ 26.37万 - 项目类别:
Development and Preclinical Evaluation of Nanoformulations in Liver Fibrotic Mice
肝纤维化小鼠纳米制剂的开发和临床前评价
- 批准号:
10639037 - 财政年份:2023
- 资助金额:
$ 26.37万 - 项目类别:
Auditory event-related potentials as in vivo preclinical assays of circuit engagement for E/I-based therapeutic development
听觉事件相关电位作为基于 E/I 的治疗开发的电路参与的体内临床前测定
- 批准号:
10717704 - 财政年份:2023
- 资助金额:
$ 26.37万 - 项目类别: